PMC:7408073 / 35452-35830 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1373","span":{"begin":119,"end":123},"obj":"Gene"},{"id":"1375","span":{"begin":26,"end":35},"obj":"Species"},{"id":"1422","span":{"begin":363,"end":371},"obj":"Gene"},{"id":"1433","span":{"begin":303,"end":311},"obj":"Gene"},{"id":"1434","span":{"begin":282,"end":290},"obj":"Gene"},{"id":"1443","span":{"begin":330,"end":334},"obj":"Gene"},{"id":"1454","span":{"begin":231,"end":243},"obj":"Gene"},{"id":"1455","span":{"begin":173,"end":185},"obj":"Gene"}],"attributes":[{"id":"A1373","pred":"tao:has_database_id","subj":"1373","obj":"Gene:116511"},{"id":"A1375","pred":"tao:has_database_id","subj":"1375","obj":"Tax:694009"},{"id":"A1422","pred":"tao:has_database_id","subj":"1422","obj":"Gene:284"},{"id":"A1433","pred":"tao:has_database_id","subj":"1433","obj":"Gene:284"},{"id":"A1434","pred":"tao:has_database_id","subj":"1434","obj":"Gene:284"},{"id":"A1443","pred":"tao:has_database_id","subj":"1443","obj":"Gene:116511"},{"id":"A1454","pred":"tao:has_database_id","subj":"1454","obj":"Gene:116511"},{"id":"A1455","pred":"tao:has_database_id","subj":"1455","obj":"Gene:116511"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" and their involvement in SARS-CoVs will be extensively discussed in the next sections, instead a brief description of MasR inhibition will be presented in the present Box.\nMas receptor pathway inhibition and side effects of using Mas receptor inhibitors. A779 also known as D-Ala7-Ang-(1–7) and D-Pro7-Ang-(1–7) are two distinct MasR antagonists able to prevent Ang-(1–7)-media"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T229","span":{"begin":26,"end":30},"obj":"Disease"}],"attributes":[{"id":"A229","pred":"mondo_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" and their involvement in SARS-CoVs will be extensively discussed in the next sections, instead a brief description of MasR inhibition will be presented in the present Box.\nMas receptor pathway inhibition and side effects of using Mas receptor inhibitors. A779 also known as D-Ala7-Ang-(1–7) and D-Pro7-Ang-(1–7) are two distinct MasR antagonists able to prevent Ang-(1–7)-media"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T416","span":{"begin":96,"end":97},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" and their involvement in SARS-CoVs will be extensively discussed in the next sections, instead a brief description of MasR inhibition will be presented in the present Box.\nMas receptor pathway inhibition and side effects of using Mas receptor inhibitors. A779 also known as D-Ala7-Ang-(1–7) and D-Pro7-Ang-(1–7) are two distinct MasR antagonists able to prevent Ang-(1–7)-media"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T313","span":{"begin":244,"end":254},"obj":"Chemical"},{"id":"T314","span":{"begin":282,"end":285},"obj":"Chemical"},{"id":"T315","span":{"begin":303,"end":306},"obj":"Chemical"},{"id":"T316","span":{"begin":335,"end":346},"obj":"Chemical"},{"id":"T317","span":{"begin":363,"end":366},"obj":"Chemical"}],"attributes":[{"id":"A313","pred":"chebi_id","subj":"T313","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A314","pred":"chebi_id","subj":"T314","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A315","pred":"chebi_id","subj":"T315","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A316","pred":"chebi_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"},{"id":"A317","pred":"chebi_id","subj":"T317","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":" and their involvement in SARS-CoVs will be extensively discussed in the next sections, instead a brief description of MasR inhibition will be presented in the present Box.\nMas receptor pathway inhibition and side effects of using Mas receptor inhibitors. A779 also known as D-Ala7-Ang-(1–7) and D-Pro7-Ang-(1–7) are two distinct MasR antagonists able to prevent Ang-(1–7)-media"}

{"project":"LitCovid-sentences","denotations":[{"id":"T167","span":{"begin":173,"end":255},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" and their involvement in SARS-CoVs will be extensively discussed in the next sections, instead a brief description of MasR inhibition will be presented in the present Box.\nMas receptor pathway inhibition and side effects of using Mas receptor inhibitors. A779 also known as D-Ala7-Ang-(1–7) and D-Pro7-Ang-(1–7) are two distinct MasR antagonists able to prevent Ang-(1–7)-media"}